The Nebraska Medical Center is the clinical teaching hospital for the University
of Nebraska Medical Center, where many of the early advancements in this field occurred
and the field grew. Patients are offered to participate in all of the latest clinical
trials for Lymphoma. These advancements have helped improve success rates and have
made bone marrow and stem cell transplants a more viable and promising option for
a growing number of patients. This includes those with malignancies that include
primarily lymphomas, leukemias, multiple myeloma as well as some blood disorders.
People come from all over the country and around the world to receive care from
the transplant program at The Nebraska Medical Center. Since its founding 25 years
ago, physicians and researchers at The Nebraska Medical Center program have been
pioneers in the field and are recognized internationally for a number of ground-breaking
advancements.
The first of these revolutionary achievements was the study and introduction of
autologous transplantation by Dr. Armitage and his colleagues at The Nebraska Medical
Center, which served as the starting point and foundation for the program’s success.
This procedure, involving using the patient’s own stem cells not only reduces rejection
issues but also provides another treatment option for people who otherwise had incurable
lymphoma.
